Alcoholism
Below is a sample of existing clinical evidence:“The administration of a single dose of bone marrow- or adipose tissue-derived MSCs reduced continuous chronic alcohol intake by 50% during 10 days… Animals treated with MSCs significantly reduced up to 80–85% their relapse-like alcohol intake compared to control rats… significantly inhibited relapse-like drinking for the 40 days investigated, suggesting a protracted remodeling.”
– “Intracerebral Stem Cell Administration Inhibits Relapse-like Alcohol Drinking in Rats,” Israel et al, Alcohol and Alcoholism, 2017
For further information regarding regenerative medicine, please refer to information provided by American Academy of Integrative Cell Therapy (AAICT).